Can tertiary prevention of hepatocellular carcinoma be achieved by nucleos(t)ide analogs therapy of hepatitis B?

Rong Nan Chien

doi:10.1111/j.1440-1746.2011.06931.x

Can tertiary prevention of hepatocellular carcinoma be achieved by nucleos(t)ide analogs therapy of hepatitis B?

Rong Nan Chien^*

^*Corresponding author for this work

Chang Gung Memorial Hospital

Research output: Contribution to journal › Journal Editorial

1 Scopus citations

Original language	English
Pages (from-to)	1699-1701
Number of pages	3
Journal	Journal of Gastroenterology and Hepatology (Australia)
Volume	26
Issue number	12
DOIs	https://doi.org/10.1111/j.1440-1746.2011.06931.x
State	Published - 12 2011
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1111/j.1440-1746.2011.06931.x

Cite this

@article{53ffafca0fe348a4bc325147b683a80b,

title = "Can tertiary prevention of hepatocellular carcinoma be achieved by nucleos(t)ide analogs therapy of hepatitis B?",

author = "Chien, \{Rong Nan\}",

year = "2011",

month = dec,

doi = "10.1111/j.1440-1746.2011.06931.x",

language = "英语",

volume = "26",

pages = "1699--1701",

journal = "Journal of Gastroenterology and Hepatology (Australia)",

issn = "0815-9319",